Search clinical trials for: BRCA1/2 ( ve)

Total 53738 results

Ruhr University of Bochum
University of British Columbia; Friedrich-Alexander-Universität Erlangen-Nürnberg

Completed

Waitlist Controlled Comparison of Cognitive-behavioral vs. Mindfulness-based Online-treatments for Women With Low Sexual Desire (MiSELF)

Hypoactive Sexual Desire Disorder

Germany
Arizona State University
National Institute on Drug Abuse (NIDA); Phoenix Indian Center; Ain Dah Yung... and other collaborators

Recruiting

Parenting in 2 Worlds Multisite Trial ((P2W))

Parenting | Substance Use | Mental Health Wellness 1 | Risky Health Behavior

United States
Vienna Institute for Research in Ocular Surgery

Recruiting

Digital Marking Systems

Cataract

Austria
University of Malaya
Pfizer; Cancer Research Malaysia; Pantai Hospital Kuala Lumpur; Hospital Sultan...

Recruiting

Efficacy of Talazoparib in Asian Metastatic Breast Cancer Patients With a Homologous Recombinant Deficiency (HRD) Signature

Triple Negative Breast Cancer | HRD 100 Gene Expression High

Malaysia
Hebei Medical University Fourth Hospital

Not yet recruiting

Olaparib in the Treatment of BRCA1/2 Unmutated and BRCA1 Promoter Methylated Recurrent and Metastatic Triple-negative Breast Cancer

Solid Tumor
Technical University of Munich

Completed

Feasibility of Lifestyle Intervention in BRCA1/2 Mutation Carriers (LIBRE)

Hereditary Breast and Ovarian Cancer

Germany
Third Affiliated Hospital, Sun Yat-Sen University

Withdrawn

The Safety and Efficacy of MSC-EVs in Acute/Acute-on-Chronic Liver Failure

Acute-On-Chronic Liver Failure | Acute Liver Failure

China
Regina Elena Cancer Institute

Recruiting

Psyco Quality of Life and Procreation BRCA1/2 (QoL)

Breast Cancer | Genetic Predisposition

Italy
Memorial Sloan Kettering Cancer Center
Memorial Health University Medical Center

Completed

BRCA1 Haploinsufficiency and Gene Expression

BRCA1 Mutations

United States
AstraZeneca
Quintiles; University of Tubingen - Germany

Completed

International Breast Cancer Biomarker,Standard of Care and Real World Outcomes Study (BREAKOUT)

Breast Cancer

United States, Bulgaria, Italy, Korea, Republic of, Russian Federation, Spain, Turkey, Canada, Poland, Australia, Hungary, Taiwan, Japan, Germany, United Kingdom
Abramson Cancer Center at Penn Medicine

Recruiting

Preliminary Evaluation of Screening for Pancreatic Cancer in Patients With Inherited Genetic Risk

Pancreatic Cancer

United States
AstraZeneca

Completed

A Phase 3 Open-label Study to Evaluate the Safety of MEDI3250 in Healthy Japanese Children Age 2 Years Through 6 Years

Healthy Japanese Children Age 2 Years Through 6 Years

Japan
Cancer Institute and Hospital, Chinese Academy...

Not yet recruiting

A Multicentre Prospective Cohort Study: Intensive Adjuvant Therapy for TNBC With BRCA Gene Mutation

Early-stage Triple-negative Breast Cancer With BRCA1/2 Mutations

China
Bayer

Completed

Ovulation Inhibition of Two 4-phasic Oral Contraceptive Regimens

Ovulation Inhibition

Germany, Netherlands
Chiesi Italia

Active, not recruiting

Effects of Beclometasone Dipropionate/Formoterol Fumarate Via NEXT(Haler) in a Real-world Study on Asthma Control (NEWTON)

Asthma

Italy
Weill Medical College of Cornell University
Basser Research Center for BRCA

Recruiting

FaCT Trial (Facilitated Cascade Testing Trial)

BRCA1 Mutation | BRCA2 Mutation

United States
University of Pennsylvania

Recruiting

Evaluating Cascade Communication Methods (ECHO)

BRCA1 Mutation | BRCA2 Mutation

United States
National Cancer Institute (NCI)

Completed

A Qualitative Exploration of the Impact of Positive BRCA1/2 Mutation Status on the Lives of Young Women

BRCA1 Gene | BRCA2 Gene

United States
Azienda Ospedaliera Universitaria Policlinico Paolo...

Unknown

BRCA Main Home Nutritional Intervention-random Study

BRCA1 Mutation | BRCA2 Mutation

Italy
Fudan University

Recruiting

Adjuvant Chemotherapy of Three-step Regimen in BRCA1/2 Wide Type Ovarian Cancer (ACTS-2)

Ovarian Cancer

China
Fondazione Policlinico Universitario Agostino Gemelli...

Recruiting

Breast Cancer After Ovarian Cancer During and/or After Therapy: Genomic Evaluation (Gen-eva)

BRCA-Associated Breast Carcinoma

Italy
National Cancer Institute (NCI)

Terminated

BMN 673 (Talazoparib), an Oral PARP Inhibitor, in People With Deleterious BRCA1/2 Mutation-Associated Ovarian Cancer Who Have Had Prior PARP Inhibitor Treatment

Ovarian Cancer

United States
Assiut University

Completed

Simulation in Teaching Vaginal Examination (VE)

Healthy

Egypt
Maíra F Pessoa

Completed

Ergospirometric Values and WBV in Elderly (EVAWIE)

Aging

Brazil
Memorial Sloan Kettering Cancer Center
University of Pennsylvania; University of California, Los Angeles; Dana-Farber... and other collaborators

Active, not recruiting

BRCA Founder OutReach (BFOR) Study (BFOR)

BRCA1 Mutation | BRCA2 Mutation

United States
Imran Niazi
Medtronic

Terminated

Dual Site Left Ventricular (LV) Pacing (DIVA)

Congestive Heart Failure | LV Dysfunction

United States
University of Pennsylvania

Recruiting

Food Genetics Behavior Study (FOODIE)

Obesity, Childhood

United States
G1 Therapeutics, Inc.

Active, not recruiting

G1T38, a CDK 4/6 Inhibitor, in Combination With Fulvestrant in Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer

Breast Cancer | Breast Neoplasm | Carcinoma, Ductal, Breast

United Kingdom, Bulgaria, Georgia, Moldova, Republic of
Impact Therapeutics, Inc.

Unknown

Study of IMP4297 in Patients With BRCA1/2 Mutation Ovarian Cancer (SABRINA)

Ovarian Cancer

China
Kirby Institute

Completed

MARCH Vascular Endothelium Substudy (MARCH VE)

Cardiovascular Disease

Argentina, Australia, Germany, Thailand
Rabin Medical Center

Unknown

The Link Between BRCA Mutation and Endothelial Function

BRCA1 Gene Mutation | BRCA2 Gene Mutation

Israel
AstraZeneca

Enrolling by invitation

Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib (ROSY-O)

Breast Cancer | Ovarian Cancer

Italy, Spain, United States, Canada, Belgium, Denmark, Korea, Republic of, Czechia, Turkey, China, United Kingdom, Taiwan, Brazil, Israel, France, Hungary, Poland, Portugal, Germany, Russian Federation, Bulgaria, Finland, Slovenia, Sw...
European Institute of Oncology

Completed

Promoting Men's Adherence to BRCA1/2 Germline Genetic Testing (BRCA-MEN)

BRCA1 Mutation | BRCA2 Mutation | Psychosocial Factors

Italy
Abbott Medical Devices
MetroHealth Medical Center; Cambridge Heart Inc.

Completed

Study to Compare TWA Test and EPS Test for Predicting Patients at Risk for Life-threatening Heart Rhythms (ABCD Study)

Ischemic Cardiomyopathy | LV Dysfunction
University of California, San Francisco
American Cancer Society, Inc.

Completed

Prospective Research of Outcomes After Salpingo-oophorectomy (PROSper)

BRCA1 Gene Mutation | BRCA2 Gene Mutation

United States
IRCCS San Camillo, Venezia, Italy
Universita di Verona; Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico and other collaborators

Enrolling by invitation

Clinical and Biochemical Features for the Identification of Dominant Calpainopathies (DOM-CAL)

Calpain-3 Deficiency Limb Girdle Muscular Dystrophy Type 2A

Italy
St. Anne's University Hospital Brno, Czech Republic
Brno University Hospital; Palacky University

Recruiting

Pre-habilitation in Lung Surgery Candidates

Lung Cancer | Post-Op Complication

Czechia
Ohio State University Comprehensive Cancer Center

Recruiting

Usefulness of Video-Based Intervention in Helping Participants Encourage Their Families to Get Tested for BRCA Gene Mutations

BRCA1 Gene Mutation | BRCA2 Gene Mutation

United States
AstraZeneca
Merck Sharp & Dohme LLC; Myriad Genetics, Inc.; Foundation Medicine, Inc.

Active, not recruiting

Clinical Study to Assess the Efficacy and Safety of Olaparib in Chinese Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Prior Treatment With a New Hormonal Agent and Have BRCA1/2 Mutations

Metastatic Castration-resistant Prostate Cancer

China
Medtronic Cardiac Rhythm and Heart Failure

Completed

Left Ventricular Capture Management Study (LEARN)

Ventricular Fibrillation | Ventricular Tachycardia | Bradyarrhythmia

Canada
Sher-E-Bangla Medical College

Recruiting

Assessment of Long-term Effects (Complications) of COVID-19 in the Southern Part of Bangladesh - a Retrospective Observational Study.

To Assess Long-term Effects of COVID-19 in Patients Who Were Affected With COVID -19

Bangladesh
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Study of Fluzoparib（SHR-3162）in BRCA1/2-mutant Relapsed Ovarian Cancer

Ovarian Cancer

China
Sheba Medical Center

Unknown

Trial of Inquiry Based Stress Reduction (IBSR) Program for BRCA1/2 Mutation Carriers

Hereditary Breast and Ovarian Cancer Syndrome

Israel
Wyeth is now a wholly owned subsidiary of Pfizer

Withdrawn

Study Evaluating The Effects Of Single Oral Doses Of NSA-789 On Auditory P50 Suppression In Schizophrenic Patients

Schizophrenia

United States, France
University of Mogi das Cruzes

Completed

Simulator of Pompage Technique for Physiotherapists

Musculoskeletal Pain | Contracture
Zagazig University

Unknown

Second Trimester Pregnancy Termination in Women With Previous Caesarean Sections

Second Trimester Abortion

Egypt
Biosense Webster EMEA

Terminated

CACAF2 Study: Catheter Ablation for Cure of Atrial Fibrillation (CACAF-2)

Atrial Fibrillation

Italy, United Kingdom, Finland
Bakirkoy Dr. Sadi Konuk Research and Training Hospital

Recruiting

Talocalcaneal Angle in Calcaneal Spur Formation

Plantar Fascitis | Foot Callus

Turkey
Mersin University

Recruiting

Effects of Information-Motivation-Behavioral Skills Model on Disease Management of Adolescents With Epilepsy

Nursing Caries

Turkey
The Affiliated Nanjing Drum Tower Hospital of Nanjing...

Unknown

Evaluation of Customized Treatment According to BRCA1 Assessment in Patients With Advanced Gastric Cancer (BREC-AGC)

Advanced Gastric Cancer

Search clinical trials for: BRCA1/2 ( ve)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Chile

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations